Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kitabgi

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
The Journal of Biological Chemistry|January 5, 2000
Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1S Barroso, F Richard, D Nicolas-Ethève, et al.
The European Journal of Neuroscience|August 2, 2008
Stromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigraA Guyon, D Skrzydelski, C Rovère, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1977
Neurotensin: specific binding to synaptic membranes from rat brainP Kitabgi, R Carraway, J Van Rietschoten, et al.
Glia|July 22, 2010
NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrinsG Le Dréau, L Kular, A B Nicot, et al.
British Journal of Pharmacology|June 1, 1994
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypesI Dubuc, J Costentin, J P Terranova, et al.
Brain Research|December 2, 1985
Characterization and autoradiographic distribution of neurotensin binding sites in the human brainA Sarrieau, F Javoy-Agid, P Kitabgi, et al.
Neuroscience Letters|August 17, 1992
Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamusP Kitabgi, I Dubuc, D Nouel, et al.
The Biochemical Journal|April 1, 1993
Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell lineJ N Bidard, F de Nadai, C Rovere, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brainD Herve, J P Tassin, J M Studler, et al.
Biochimie|October 1, 1983
[Radioactive analogs of neurotensin. II. Preparation of tritiated neurotensin from a synthetic multi-unsaturated derivative]C Labbé-Jullié, D Blanot, J L Morgat, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|January 5, 2000
Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1S Barroso, F Richard, D Nicolas-Ethève, et al.
The European Journal of Neuroscience|August 2, 2008
Stromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigraA Guyon, D Skrzydelski, C Rovère, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1977
Neurotensin: specific binding to synaptic membranes from rat brainP Kitabgi, R Carraway, J Van Rietschoten, et al.
Glia|July 22, 2010
NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrinsG Le Dréau, L Kular, A B Nicot, et al.
British Journal of Pharmacology|June 1, 1994
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypesI Dubuc, J Costentin, J P Terranova, et al.
Brain Research|December 2, 1985
Characterization and autoradiographic distribution of neurotensin binding sites in the human brainA Sarrieau, F Javoy-Agid, P Kitabgi, et al.
Neuroscience Letters|August 17, 1992
Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamusP Kitabgi, I Dubuc, D Nouel, et al.
The Biochemical Journal|April 1, 1993
Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell lineJ N Bidard, F de Nadai, C Rovere, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brainD Herve, J P Tassin, J M Studler, et al.
Biochimie|October 1, 1983
[Radioactive analogs of neurotensin. II. Preparation of tritiated neurotensin from a synthetic multi-unsaturated derivative]C Labbé-Jullié, D Blanot, J L Morgat, et al.
Pageof 14